A new study provides a rational for treating breast cancer by combining two kinds of targeted agents, one that inhibits an overactive, cancer-causing pathway in cancer cells and one that reverses changes that silence genes that normally prevent cancer.
Johnson & Johnson said it is recalling nearly 47 million packages of Tylenol, Sudafed and other nonprescription drugs manufactured at a Pennsylvania facility that has already been subject to a series of massive recalls.
Genedata, a provider of advanced software solutions for drug discovery and life science research, has announced the ninth version of Genedata Screener, a comprehensive software system for high content data analysis.
Illumina, Inc. announced MiSeq, a low-cost personal sequencing system that provides individual researchers a platform with rapid turnaround time, unmatched accuracy, and radically improved ease of use.
New research shows that oncolytic viruses, which are engineered to destroy cancer cells, might be more effective in treating deadly brain tumors if equipped with an enzyme that helps them penetrate the tumor.
The inhibition or removal of an enzyme may prevent or treat ischemic retinopathy by stalling growth of unwanted vessels in the retina. Ischemic retinopathy is characterized by uncontrolled formation of new blood vessels in the retina.
Federal health officials are warning doctors and patients that a recently-launched heart drug from Sanofi-Aventis SA has been linked to liver damage in a handful of patients.
Drug and medical device maker Abbott Laboratories said it withdrew its request for U.S. and European approval of the potential psoriasis drug briakinumab.
Cumberland Pharmaceuticals Inc. said the Food and Drug Administration approved a new formulation of its Acetadote injection used to treat acetaminophen poisoning.
Federal health regulators are limiting a key ingredient found in Vicodin, Percocet and other prescription painkillers that have been linked to thousands of cases of liver damage each year.
The need for pharmaceutical R&D organizations to manage expanding volumes of data crucial will require a change in focus and approach.
Cancer Research UK’s drug development office has signed a Strategic Combinations Alliance with AstraZeneca to take combinations of experimental cancer drugs into early phase clinical trials.
Irked by weakened pipelines and growing pressure from patent expiries, the big pharma majors such as AstraZeneca and Pfizer found vaccines industry as safe avenue to invest and register guaranteed revenues.
Researchers report that they are the first to show in molecular detail how one gene evolved two competing functions that eventually split up – via gene duplication – to pursue their separate destinies.
Coffee, that morning elixir, may give us an early jump-start to the day, but numerous studies have shown that it also may be protective against type 2 diabetes. Yet no one has really understood why.